Disc Medicine to Participate in Upcoming Investor Conferences
Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in hematologic disease treatments, has announced its participation in four major upcoming investor conferences in March 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in hematologic disease treatments, has announced its participation in four major upcoming investor conferences in March 2025.
The company will deliver presentations at:
- TD Cowen 45th Annual Health Care Conference in Boston (March 5th, 9:10 a.m. ET)
- Leerink Global Healthcare Conference in Miami (March 10th, 2:20 p.m. ET)
- Barclays 27th Annual Global Healthcare Conference in Miami (March 13th, 9:30 a.m. ET)
- Jefferies Biotech on the Beach Summit in Miami (March 11th)
Live webcasts of the presentations and fireside chats will be accessible through Disc Medicine's investor relations website, with archived replays available post-event.
Details
News Market Reaction – IRON
The recorded move for IRON in the trading session of this news was +1.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at three upcoming investor conferences:
- TD Cowen 45th Annual Health Care Conference (Boston, MA): Corporate presentation on Wednesday, March 5th at 9:10 a.m. ET.
- Leerink Global Healthcare Conference (Miami, FL): Fireside chat on Monday, March 10th at 2:20 p.m. ET.
- Barclays 27th Annual Global Healthcare Conference (Miami, FL): Fireside chat on Thursday, March 13th at 9:30 a.m. ET.
Disc management will be participating in investor meetings during each of the above conferences, as well as the Jefferies Biotech on the Beach Summit in Miami, FL. The Jefferies meetings take place on Tuesday, March 11th.
Live webcasts of the corporate presentation and fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.
Media Contact
Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com
Investor Relations Contact
Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.